All News

Although muscle-invasive disease is often treated by removal of the bladder, experts reveal potential high risk of death.

St. Jude Children’s Research Hospital is offering cloud-based access to the fully sequenced genomes of 10,000 pediatric patients with cancer, in the hopes that sharing the information will lead to the highest possible number of treatment breakthroughs.

As a breast cancer survivor, I have become more active in my efforts to call attention to problems with secondhand smoke in my community. Since I know that exposure is not healthy, lobbying for changes in attitudes, as well as policies, makes me feel more empowered.

At the 2019 Genitourinary Cancers Symposium, Arjun V. Balar discussed the past, present and future of immunotherapy for the treatment of bladder cancer.

Rose Gerber, of the Community Oncology Alliance, shared her story of participating in a clinical trial and hopes for others to help educate patients with breast cancer to increase participation moving forward.

At CURE’s patient-focused meeting at the 36th Annual Miami Breast Cancer Conference, Shannon Pulaski and Ellen Matloff discussed the importance of genetic counseling and learning more about one’s family health history.

Helping others is the last phase of recovery.

The Food and Drug Administration (FDA) has granted an approval to Trazimera (PF-05280014; trastuzumab-qyyp), a Herceptin (trastuzumab) biosimilar, to treat patients with HER2-overexpressing breast cancer as well as HER2-overexpressing metastatic gastric or gastroesophageal junction adenocarcinoma.

Many people believe that genetic testing for cancer can only be beneficial for individuals with a strong family history of the disease, but that is not necessarily the case.

In conjunction with Kidney Cancer Awareness Month, learn more about risk factors and treatment options for the disease.

After a review of more than 600,000 people, researchers discovered an association between foods consumed and bladder cancer risk.

The Food and Drug Administration approved the VENTANA PD-L1 (SP142) Assay as the first companion diagnostic to aid in identifying patients with triple-negative breast cancer who are eligible for treatment with Tecentriq (atezolizumab) plus chemotherapy.

Deborah A. Boyle, MSN, RN, AOCNS, FAAN, describes two types of cancer survivorship care plans that are increasing in popularity across the US.

Success with new treatments helped me realize I need to reinforce to myself and to other cancer survivors that hope is just around the corner when we least expect it.

Breast cancer treatment is a life-saver but also can have side effects, including some related to shoulder pain. It is good to start doing the exercises as soon as the doctor recommends it. After that, a regular tune-up with a physical therapist can help.

The Food and Drug Administration has granted an accelerated approval to the frontline combination of Tecentriq (atezolizumab) plus Abraxane (nab-paclitaxel) for patients with unresectable locally advanced or metastatic PD-L1–positive triple-negative breast cancer (TNBC).

From artificial intelligence to a surprise FDA resignation, check out this week’s quick overview of what is making headlines in the cancer space.

Time-limited treatment could be the new wave of research in the treatment of chronic lymphocytic leukemia (CLL), according to Nicole Lamanna, M.D.

The oral blood thinner Xarelto (rivaroxaban) significantly reduced blood clots for high-risk patients with cancer being treated in the outpatient setting, according to results from the CASSINI trial.

We've got a sneak peek at what’s inside our Winter 2019 issue.

Does your cancer diagnosis grow your patience and ability to live with change and cope with the unknown? Absolutely.

An expert describes how far the field has come, with two treatments approved and more in the works.

Sameek Roychowdhury, M.D., Ph.D., discusses the importance of molecular testing to determine treatment options for cholangiocarcinoma.

Alex Trebek, the long-time host of the popular game show "Jeopardy!", announced that he received a diagnosis of stage 4 pancreatic cancer.

Recovering from cancer and its aftermath is like grief; always changing, undulating and rippling like a tide.

Frontline use of Bavencio (avelumab) plus Inlyta (axitinib) significantly improved progression-free survival compared with the standard of care in patients with advanced renal cell carcinoma.

Partnerships to Coincide with NCAA Basketball Tournaments

This survivor details her journey with breast implants following a modified radical mastectomy.